IL17A and rheumatoid arthritis: IL-6R blockade by 22 inhibited Th17 cell differentiation, IL-17A secretion and STAT3 phosphorylation in mouse CD4+ cells (under Th17 polarization conditions) in vitro and ameliorated RA symptoms in the CIA mouse model [106].